REGULATED PRESS RELEASE published on 03/29/2024 at 17:45, 1 year 11 months ago NFL BIOSCIENCES: 2023 FULL-YEAR BUSINESS AND EARNINGS UPDATE
BRIEF published on 03/11/2024 at 09:00, 2 years ago NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP NFL Biosciences PORTZAMPARC BNP Paribas Biopharmaceutical Industry Analyst Coverage
BRIEF published on 03/11/2024 at 09:00, 2 years ago NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS Marché Financier NFL Biosciences PORTZAMPARC BNP Paribas Couverture Analyste
REGULATED PRESS RELEASE published on 03/11/2024 at 08:55, 2 years ago NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP
REGULATED PRESS RELEASE published on 03/11/2024 at 08:55, 2 years ago NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS
ARTICLE published on 02/13/2024 at 18:45, 2 years 1 month ago NFL BIOSCIENCES ANNONCE SA PARTICIPATION AU CONGRÈS DE LA SRNT Présentation des résultats prometteurs de l'étude PRECESTO dans la lutte contre le tabagisme NFL Biosciences Innovation NFL-101 Tabagisme SRNT
REGULATED PRESS RELEASE published on 02/13/2024 at 17:45, 2 years 1 month ago NFL BIOSCIENCES WILL PRESENT THE RESULTS OF THE PRECESTO CLINICAL STUDY AT THE SRNT CONFERENCE, THE WORLD'S LEADING SCIENTIFIC SOCIETY IN THE FIELD OF NICOTINE AND TOBACCO RESEARCH NFL Biosciences to present promising results of the PRECESTO clinical study at the SRNT Conference, focusing on smoking cessation with botanical drug NFL-101. Phase 2b trial ongoing for CESTO 2 NFL Biosciences Smoking Cessation NFL-101 PRECESTO Study CESTO 2
REGULATED PRESS RELEASE published on 02/13/2024 at 17:45, 2 years 1 month ago NFL BIOSCIENCES PRÉSENTERA LES RÉSULTATS DE L’ÉTUDE PRECESTO LORS DU CONGRÈS DE LA SRNT, LA SOCIÉTÉ SCIENTIFIQUE DE RÉFÉRENCE AU NIVEAU MONDIAL DANS LA LUTTE CONTRE LE TABAGISME NFL Biosciences présentera les résultats de l'étude PRECESTO lors du congrès de la SRNT à Édimbourg le 20-23 mars 2024, montrant l'efficacité de NFL-101 dans la réduction de la satisfaction de fumer NFL Biosciences NFL-101 Étude PRECESTO Tabagisme SRNT
REGULATED PRESS RELEASE published on 01/30/2024 at 08:00, 2 years 1 month ago NFL BIOSCIENCES: SUCCESS OF THE STUDY WITH THE CEA NFL BIOSCIENCES announces the successful study with the CEA demonstrating a new mechanism of action for smoking cessation using NFL-101, a botanical drug. Results open new possibilities for addiction treatment NFL Biosciences Addiction Treatment CEA Study Smoking Cessation NFL-101
REGULATED PRESS RELEASE published on 01/30/2024 at 08:00, 2 years 1 month ago NFL BIOSCIENCES : SUCCÈS DE L’ÉTUDE AVEC LE CEA NFL BIOSCIENCES annonce la mise en ubrique, étude d'imagerie moléculaire menée par le CEA, du mécanisme d'action innovant du candidat médicament NFL-101 pour le sevrage tabagique NFL Biosciences Étude D'imagerie Moléculaire Sevrage Tabagique CEA Mécanisme D'action
Published on 03/26/2026 at 08:05, 1 hour 40 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 4 hours 50 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 9 hours 5 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 9 hours 15 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 14 hours 30 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/26/2026 at 09:35, 10 minutes ago BORICA Reveals How Bulgaria Executed Euro Payments Cutover at National Scale in Partnership with OpenWay
Published on 03/26/2026 at 09:20, 25 minutes ago yoummday Wins a Texas Instruments 2025 Supplier Excellence Award
Published on 03/26/2026 at 09:05, 40 minutes ago Rockwell Automation Showcases Autonomous Industrial Operations at Hannover Messe 2026
Published on 03/26/2026 at 09:00, 44 minutes ago Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 03/26/2026 at 07:30, 2 hours 15 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 2 hours 15 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 14 hours 51 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026